The IFN-γ/miniTrpRS signaling axis: An insight into the pathophysiology of osteoporosis and therapeutic potential
Authors:
- 20 January 2022
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 64, 7-11
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Advances in Glucocorticoid-Induced OsteoporosisCurrent Rheumatology Reports, 2011
- Which fractures are most attributable to osteoporosis?Journal of Clinical Epidemiology, 2011
- Elevated IFN-γ can indirectly cause bone loss in osteoporosisNature Clinical Practice Rheumatology, 2007
- IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activationJournal of Clinical Investigation, 2007
- KYNURENINE PATHWAY METABOLISM IN PATIENTS WITH OSTEOPOROSIS AFTER 2 YEARS OF DRUG TREATMENTClinical and Experimental Pharmacology and Physiology, 2006
- Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritisAnnals of the Rheumatic Diseases, 2006
- NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000Southern Medical Journal, 2001
- Large vessel vasculitidesCurrent Opinion in Rheumatology, 1998
- Perspective how many women have osteoporosis?Journal of Bone and Mineral Research, 1992
- Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes.Journal of Experimental Medicine, 1982